Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
Published in Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM), 2024
Recommended citation: Medel, V., Delano, P. H., Belkhiria, C., et al. (2024). Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 16, e12467. https://doi.org/10.1002/dad2.12467 https://alz-journals.onlinelibrary.wiley.com/doi/epdf/10.1002/dad2.12467
Co-authored a study investigating the relationship between cochlear function and cognitive decline risk using physiological signal analysis.
The work analyzes otoacoustic emissions (DPOAEs) as quantitative indicators of auditory system integrity, linking signal-based features to early stages of neurodegeneration.
Results suggest that cochlear dysfunction can serve as an early, non-invasive biomarker, enabling improved detection and monitoring of cognitive decline in aging populations.